U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

Cover of StatPearls

StatPearls [Internet].

Show details

Castor Oil

; .

Author Information and Affiliations

Last Update: May 24, 2024.

Continuing Education Activity

Castor oil is a vegetable oil derived from the Ricinus communis plant, which is common in the Eastern areas of the world. Although castor oil is primarily known for its laxative properties, it has been reported to have additional benefits, such as aiding uterine contraction, lipid metabolism, and antimicrobial activity. Despite its traditional use, the US Food and Drug Administration (FDA) has only approved the use of castor oil as a stimulative laxative. However, although castor oil is not recommended as a first-line treatment for constipation according to current medical guidelines, it continues to be utilized in traditional practices. Although not frequently used in modern medicine, castor oil may be justified when patients prefer a more natural approach. With more scientific literature on its mechanism of action, adverse effect profile, and toxicity, castor oil is now considered safe and effective according to FDA standards.

This activity will highlight the indications, actions, and contraindications for castor oil in medical procedures and constipation. Healthcare professionals must approach the prescription cautiously due to potential adverse effects and the lack of robust clinical evidence supporting efficacy compared to modern treatments. This activity focuses on how clinicians, well-positioned to integrate traditional knowledge with evidence-based medicine, can offer informed guidance and evidence-based interventions within clinical practice. This approach enhances patient safety and optimizes care outcomes for individuals with constipation.

Objectives:

  • Identify appropriate indications for the use of castor oil based on patient symptoms and medical history.
  • Implement evidence-based guidelines for the safe and effective administration of castor oil in clinical practice.
  • Select alternative treatment options when castor oil is contraindicated or inappropriate for the patient.
  • Collaborate with other healthcare professionals, including pharmacists and alternative medicine specialists, to ensure comprehensive patient care.
Access free multiple choice questions on this topic.

Indications

Castor oil is a vegetable oil derived from the Ricinus communis plant, which is common in the Eastern areas of the world. Castor oil is not frequently used in modern medicine, but its utility is justified when patients prefer a more natural approach. As castor oil is derived from the plant R communis, many patients may prefer its use due to its natural growth, which inherently seems nontoxic and safer than traditional medicine.[1] With more scientific literature on castor oil's mechanism of action, adverse effect profile, and toxicity, the treatment is now completely safe and effective according to the US Food and Drug Administration (FDA) standards. 

FDA-Approved Indications

Despite its traditional use, the FDA has only approved the use of castor oil as a stimulative laxative for the temporary relief of occasional constipation. However, its use has declined over the years as research has produced more effective laxatives with fewer adverse effects. Castor oil can be beneficial for medical procedures, particularly in diagnostic tests such as colonoscopies, where bowel prep is essential before performing the procedure.[2] Although castor oil may be used for bowel evacuation, patients typically experience better results and satisfaction with other laxatives such as sennosides, polyethylene glycol (PEG), and bisacodyl. In a study comparing castor oil to senna syrup, the senna group had fewer adverse effects and better bowel preparation.[3] Additionally, a meta-analysis suggests that castor oil is useful for capsule colonoscopy, improving completion rates and polyp detection

The treatment is safe, but more studies are needed to confirm these findings.[4][5] A retrospective study compared a 2-L PEG with castor oil (PEG-CaO) solution to the standard 4-L split PEG solution for colonoscopy preparation in hospitalized patients. The group receiving the 2-L PEG-CaO solution scored higher on the Boston Bowel Preparation Scale (BBPS), indicating better bowel cleansing. Additionally, this group had a higher success rate of adequate bowel preparation and experienced fewer adverse effects than the 4-L PEG group. These findings suggest that the 2-L PEG-CaO solution is a viable alternative for bowel preparation before colonoscopy in hospitalized patients.[6]

Off-Label Uses

Although other uses of castor oil exist, these indications are not FDA-approved. These uses include wound healing, arthritis, headache, menstrual cramps, and labor induction. While these uses have been common in alternative medicine for hundreds of years, scientific evidence is insufficient to support these claims in modern medicine.[7] With chronic idiopathic constipation being one of the most common gastrointestinal complaints, castor oil is of significant benefit.[8] 

A study examined the use of castor oil for labor induction in 70 women with 1 prior cesarean section. While castor oil shows promise, further research is needed to confirm its safety.[9] A review assessed various pharmacological agents, mechanical methods, and complementary approaches for cervical ripening and labor induction. Although prostaglandins, oxytocin, and misoprostol are commonly used and supported by research, complementary methods, such as castor oil, lack sufficient evidence for efficacy and safety in hospital settings.[10]

Another study summarizes the potential therapeutic benefits of castor oil in managing blepharitis, dry eye disease, and meibomian gland dysfunction. However, additional research is needed to understand the therapeutic potential thoroughly.[11]

Mechanism of Action

The main chemical with laxative properties in castor oil is ricinoleic acid. In the intestine, lipase breaks down castor oil into ricinoleic acid, which activates EP3 and EP4 prostanoid receptors in smooth muscle cells. This activation creates a transient calcium surge, causing propulsion in the intestine. Due to this mechanism of action, castor oil falls into the stimulant laxative category, similar to bisacodyl and sennosides. EP3 and EP4 prostanoid receptors are also present in the uterus, suggesting the potential use of castor oil for labor induction; however, more research is necessary on this subject.[12]

Pharmacokinetics

Absorption: Following administration, castor oil undergoes a process where lipases in the intestinal lumen release ricinoleic acid, which is then absorbed in the intestine. Preclinical research indicates that the absorption of castor oil is inversely proportional to the dosage administered. However, absorption is nearly complete at smaller doses, such as 4 g. The onset of action is usually within 1 to 3 hours.

Distribution: The information regarding the volume of distribution is unavailable.

Metabolism: Castor oil is broken down by pancreatic enzymes within the small intestine, which liberates glycerol and ricinoleic acid. Ricinoleic acid then undergoes systemic metabolism, excreting the resulting metabolites. As expected, pancreatic and intestinal lipases facilitate the degradation of fatty acids.

Excretion: The excretion of castor oil in feces varies between 11.4% (for a 10 g dose) and 86% (for a 44.4 g dose).

Administration

Available Dosage Forms and Strengths

Castor oil is taken orally and must be broken down by intestinal lipases to produce the stimulant laxative effects. Castor oil is available as a 100% oral solution and can be purchased over the counter.

Adult Dosage

An appropriate daily dosage for an adult male is 15 to 60 mL. Taking castor oil with juice may improve the taste.

Specific Patient Populations

Hepatic impairment: The product label does not provide dosage adjustments for castor oil; therefore, it should be used cautiously.

Renal impairment: The product label does not provide dosage adjustments for castor oil; therefore, it should be used cautiously.

Pregnancy considerations: In the early 1950s, over half of academic obstetrical departments in the United States administered castor oil alone or combined with soap suds enemas. With the advent of pharmacological interventions, castor oil is no longer used in hospitals in high-income countries. However, the general public still uses the treatment in low-resource settings. Potential complications include meconium staining and maternal electrolyte abnormalities due to diarrhea.[10] Ingesting castor oil during pregnancy may induce labor, so use as a laxative is contraindicated.

Breastfeeding considerations: Castor oil is a potent stimulant laxative. Homeopathic preparations of castor oil are sometimes used to reduce milk flow or as a galactagogue, although no scientifically valid clinical trials support these uses. Some preparations can be toxic to infants. Galactagogues should not replace evaluation and counseling on modifiable factors affecting milk production. No data exist on the excretion of castor plant components into breast milk or their safety and efficacy in nursing mothers or infants. Due to the lack of information, other laxatives may be preferred during lactation. The administration of castor oil to infants is risky and should be avoided due to adverse effects.[13]

Pediatric patients: Castor oil is frequently used in teas in newborn Haitian children to facilitate the passage of meconium stool or treat minor illnesses. Although typically administered in small doses, larger volumes are occasionally used, leading to significant risks. This traditional practice is underdocumented and can result in adverse outcomes. Consequently, administering castor oil to newborns is not advisable and should be avoided.[14] As per the product labeling, adults and children aged 12 and older can take 1 to 4 tablespoons of castor oil daily, as advised by a clinician. The recommended dosage for children between the ages of 2 and 12 is 1 to 3 teaspoons daily or as directed by a clinician.

Older patients: Castor oil should be used cautiously in older patients due to the increased risk of adverse effects related to potential renal and cardiac impairment, as well as possible fluid and electrolyte imbalance.

Adverse Effects

The adverse effects of castor oil are a common reason for its infrequent use in conventional medicine. In a study comparing castor oil to sennosides, castor oil was more likely to cause abdominal cramping, vomiting, bloating, and dizziness. Far fewer adverse effects occurred with the use of other laxatives.[3]

Few studies have also proposed that long-term use of a stimulant laxative may create a cathartic colon due to anatomic changes. However, more recent evidence suggests that a "cathartic colon" is not an actual condition.[15] Additionally, a study identified castor oil, often used in lip care products, as a potential trigger for allergic contact dermatitis. Patients with sensitive skin who use castor oil-containing lip balms or glosses may develop symptoms like pruritus and erythema on the lips. While not universally applicable, these findings suggest that some individuals are susceptible to allergic reactions to castor oil.[16]

Drug-Drug Interactions

The use of stimulant laxatives alongside castor oil is not recommended due to the risk of adverse effects, particularly gastrointestinal complications.

Contraindications

With castor oil affecting smooth muscle, recommendations advise against its use in pregnancy, as this can lead to premature contractions. Contraindications to stimulant laxatives also include various abdominal pathologies such as gastrointestinal obstruction, appendicitis, perforation, and inflammatory bowel disease.[17]

Monitoring

As with any laxative, it is advisable to monitor for electrolyte disturbances and acid-base disorders. Imbalances may occur due to the loss of bicarbonate, water, and electrolytes, which can worsen with diarrhea. Physical examination signs in the patient may include rapid breathing, confusion, sleepiness, vomiting, and weakness, especially in cases of electrolyte disturbances and acid-base imbalances. These issues can potentially be lethal if not addressed immediately. 

The treating clinician should also monitor patients for laxative abuse. Patients with anorexia nervosa or bulimia are especially at risk as they may try to decrease weight through laxative abuse. Such abuse can be detrimental due to the loss of minerals, nutrition, and electrolytes.[18]

Toxicity

Signs and Symptoms of Overdose

The castor plant, R communis, is known to contain a toxic chemical called ricin. If an individual eats Ricinus seeds directly, the ricin toxin can take effect in as little as 4 to 12 hours. Signs and symptoms of ricin toxicity include gastrointestinal bleeding, shock, pulmonary edema, and inflammation. These symptoms occur due to the inactivating effect of ricin toxin on ribosomes, which renders the body unable to create proteins. Castor bean ingestion can result in two distinct clinical effects—acute and late-phase manifestations.

During the acute phase, patients commonly experience gastrointestinal symptoms. Conversely, the late phase is characterized by cytotoxic effects on the kidney, liver, and adrenal gland, typically manifesting 2 to 5 days post-exposure. Ricin toxicity affects multiple body systems, often presenting with fever as a prominent clinical feature. Fever onset can occur within 30 minutes to 2 hours after ingesting 1 to 4 beans.[19] Due to ricin's water-soluble properties, the castor oil extraction process negates these toxic properties.[20] Castor oil is purified with ricin during the extraction process. Castor oil is completely safe for human consumption with minimal toxic effects in both acute and chronic settings and has demonstrated no genotoxic effects. Castor oil is also used widely for nonmedical purposes, such as lubrication, cosmetics, and coatings.[2] 

Management of Overdose

Clinicians need to provide supportive care to patients during ricin toxicity, as a specific antidote for castor oil toxicity is currently not available. Replenishing intravenous fluids and electrolytes is essential for managing gastroenteritis.

Enhancing Healthcare Team Outcomes

The healthcare team is responsible for maintaining professionalism, ethics, and respect for the patient's decisions regarding their care. Given the natural quality of castor oil, many patients may prefer this treatment option. With increased scientific research regarding castor oil and its longstanding historical use, clinicians can confidently consider prescribing this medication. However, the clinician must conduct a thorough examination and appropriate diagnosis before determining whether castor oil is suitable, considering the various contraindications that may exist. 

After prescribing the medication, monitoring the patient involves observing for adverse effects. As the primary contact for patient care, nurses can assist the physician in identifying any abnormalities in patient behavior, including signs of electrolyte imbalances, acid-base disorders, or dehydration. Lastly, a pharmacist can aid the team with appropriate dosing and drug interactions. Castor oil is a potent laxative, so the absorption of other oral drugs may be severely affected. Overall, the interprofessional healthcare team must collaborate to ensure positive outcomes.

Review Questions

References

1.
Frass M, Strassl RP, Friehs H, Müllner M, Kundi M, Kaye AD. Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review. Ochsner J. 2012 Spring;12(1):45-56. [PMC free article: PMC3307506] [PubMed: 22438782]
2.
Final report on the safety assessment of Ricinus Communis (Castor) Seed Oil, Hydrogenated Castor Oil, Glyceryl Ricinoleate, Glyceryl Ricinoleate SE, Ricinoleic Acid, Potassium Ricinoleate, Sodium Ricinoleate, Zinc Ricinoleate, Cetyl Ricinoleate, Ethyl Ricinoleate, Glycol Ricinoleate, Isopropyl Ricinoleate, Methyl Ricinoleate, and Octyldodecyl Ricinoleate. Int J Toxicol. 2007;26 Suppl 3:31-77. [PubMed: 18080873]
3.
Ghazikhanlou Sani K, Jafari MR, Shams S. A comparison of the efficacy, adverse effects, and patient compliance of the sena-graph®syrup and castor oil regimens for bowel preparation. Iran J Pharm Res. 2010 Spring;9(2):193-8. [PMC free article: PMC3862068] [PubMed: 24363727]
4.
Deding U, Jensen SS, Schelde-Olesen B, Kaalby L, Bjørsum-Meyer T, Koulaouzidis A. Castor Oil in Bowel Preparation Regimens for Colon Capsule Endoscopy: A Systematic Review with Meta-Analysis. Diagnostics (Basel). 2022 Nov 15;12(11) [PMC free article: PMC9688971] [PubMed: 36428855]
5.
Mizukami K, Inumaru Y, Akiyama H, Fukuda K, Okamoto K, Fujioka T, Okimoto T, Murakami K. Efficacy of the Castor Oil-Filled Capsule Method as Preparation for Colon Capsule Endoscopy. Digestion. 2023;104(5):409-414. [PubMed: 37071981]
6.
Xiong Z, Fang Y, Feng F, Cheng Y, Huo C, Huang J. 2L polyethylene glycol combined with castor oil versus 4L polyethylene glycol for bowel preparation before colonoscopy among inpatients. Medicine (Baltimore). 2023 Jul 21;102(29):e34294. [PMC free article: PMC10662855] [PubMed: 37478260]
7.
Marwat SK, Rehman F, Khan EA, Baloch MS, Sadiq M, Ullah I, Javaria S, Shaheen S. Review - Ricinus cmmunis - Ethnomedicinal uses and pharmacological activities. Pak J Pharm Sci. 2017 Sep;30(5):1815-1827. [PubMed: 29084706]
8.
Black CJ, Ford AC. Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management. Med J Aust. 2018 Jul 16;209(2):86-91. [PubMed: 29996755]
9.
Bayoumi YA, Alalfy M, Sharkawy M, Ali AS, Gouda HM, Hatem DL. Castor oil for labor initiation in women with a previous cesarean section: a double-blind randomized study. J Matern Fetal Neonatal Med. 2022 Dec;35(25):8945-8951. [PubMed: 34886746]
10.
Sanchez-Ramos L, Levine LD, Sciscione AC, Mozurkewich EL, Ramsey PS, Adair CD, Kaunitz AM, McKinney JA. Methods for the induction of labor: efficacy and safety. Am J Obstet Gynecol. 2024 Mar;230(3S):S669-S695. [PubMed: 38462252]
11.
Sandford EC, Muntz A, Craig JP. Therapeutic potential of castor oil in managing blepharitis, meibomian gland dysfunction and dry eye. Clin Exp Optom. 2021 Apr;104(3):315-322. [PubMed: 33037703]
12.
Tunaru S, Althoff TF, Nüsing RM, Diener M, Offermanns S. Castor oil induces laxation and uterus contraction via ricinoleic acid activating prostaglandin EP3 receptors. Proc Natl Acad Sci U S A. 2012 Jun 05;109(23):9179-84. [PMC free article: PMC3384204] [PubMed: 22615395]
13.
Drugs and Lactation Database (LactMed®) [Internet]. National Institute of Child Health and Human Development; Bethesda (MD): Jun 21, 2021. Castor. [PubMed: 30000935]
14.
Jean Baptiste W, Casseus M, Dev A, Joseph P, Wright PF. The dangers of castor oil tea in neonates in rural Haiti: A case report. Front Pediatr. 2023;11:877550. [PMC free article: PMC10025402] [PubMed: 36950175]
15.
Portalatin M, Winstead N. Medical management of constipation. Clin Colon Rectal Surg. 2012 Mar;25(1):12-9. [PMC free article: PMC3348737] [PubMed: 23449608]
16.
Pal B, Kumari S, Kumari A, Singh SK, Babbar H. Allergic contact dermatitis to lip care cosmetic products - a systematic review. Cutan Ocul Toxicol. 2024 Mar;43(1):13-21. [PubMed: 37904533]
17.
Xing JH, Soffer EE. Adverse effects of laxatives. Dis Colon Rectum. 2001 Aug;44(8):1201-9. [PubMed: 11535863]
18.
Roerig JL, Steffen KJ, Mitchell JE, Zunker C. Laxative abuse: epidemiology, diagnosis and management. Drugs. 2010 Aug 20;70(12):1487-503. [PubMed: 20687617]
19.
Al-Tamimi FA, Hegazi AE. A case of castor bean poisoning. Sultan Qaboos Univ Med J. 2008 Mar;8(1):83-7. [PMC free article: PMC3087745] [PubMed: 21654963]
20.
Worbs S, Köhler K, Pauly D, Avondet MA, Schaer M, Dorner MB, Dorner BG. Ricinus communis intoxications in human and veterinary medicine-a summary of real cases. Toxins (Basel). 2011 Oct;3(10):1332-72. [PMC free article: PMC3210461] [PubMed: 22069699]

Disclosure: Jeffrey Alookaran declares no relevant financial relationships with ineligible companies.

Disclosure: Jayson Tripp declares no relevant financial relationships with ineligible companies.

Copyright © 2024, StatPearls Publishing LLC.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.

Bookshelf ID: NBK551626PMID: 31869090

Views

  • PubReader
  • Print View
  • Cite this Page

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...